Telomeres cap and protect the ends of all human chromosomes. In healthy adult tissue, telomeres shorten with each round of cell division as part of the normal aging process. This mechanism limits human cells to a finite number of cell divisions before induction of programmed cell death and therefore serves as a tumor suppressor. In cancer cells, however, an enzyme called telomerase is upregulated to nullify the limited number of cell divisions. As such, cancer cells are capable of infinite division, which allows proliferation of ~90% of all malignant tumors. Due to this unique and critical role in cancer biology, telomerase provides a novel target for innovative therapeutics. The purpose of the present proposal is to explore a novel mechanism toward using telomerase as an anti-cancer target. In our approach, we will design non-native nucleotide analogs to be preferentially and selectively incorporated by telomerase into telomere DNA. Once incorporated, the non-native nucleotides should abrogate binding of essential telomere-end binding proteins such as the Protection of Telomeres 1 (POT1), which is highly specific for telomere DNA sequence. Abrogation of POT1 binding induces cell death through a cascade of DNA damage events. The cell-killing potential of these non-native nucleotide compounds will be validated by measuring their potency and selectivity against telomerase-positive cancer cell lines as well as xenograft mouse models. We predict that our strategy will provide a selective mechanism to potentially treat a wide range of human cancers.

National Institute of Health (NIH)
National Cancer Institute (NCI)
NIH Director’s New Innovator Awards (DP2)
Project #
Application #
Study Section
Program Officer
Ogunbiyi, Peter
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
Schools of Medicine
United States
Zip Code
Scott, Harry; Huang, Wei; Bann, James G et al. (2018) Advances in structure determination by cryo-EM to unravel membrane-spanning pore formation. Protein Sci 27:1544-1556
Zeng, Xuehuo; Hernandez-Sanchez, Wilnelly; Xu, Mengyuan et al. (2018) Administration of a Nucleoside Analog Promotes Cancer Cell Death in a Telomerase-Dependent Manner. Cell Rep 23:3031-3041
Basak, Sandip; Gicheru, Yvonne; Samanta, Amrita et al. (2018) Cryo-EM structure of 5-HT3A receptor in its resting conformation. Nat Commun 9:514
Scott, Harry; Kim, Jin-Kwang; Yu, Clinton et al. (2017) Spatial Organization and Molecular Interactions of the Schizosaccharomyces pombe Ccq1-Tpz1-Poz1 Shelterin Complex. J Mol Biol 429:2863-2872
Rajavel, Malligarjunan; Orban, Tivadar; Xu, Mengyuan et al. (2016) Dynamic peptides of human TPP1 fulfill diverse functions in telomere maintenance. Nucleic Acids Res 44:10467-10479
Wang, Y; Deng, O; Feng, Z et al. (2016) RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression. Oncogene 35:1363-72
Mullins, Michael R; Rajavel, Malligarjunan; Hernandez-Sanchez, Wilnelly et al. (2016) POT1-TPP1 Binding and Unfolding of Telomere DNA Discriminates against Structural Polymorphism. J Mol Biol 428:2695-708
Rajavel, Malligarjunan; Mullins, Michael R; Taylor, Derek J (2014) Multiple facets of TPP1 in telomere maintenance. Biochim Biophys Acta 1844:1550-9